Below are the most recent publications written about "Parkinson Disease" by people in Profiles.
-
Tizabi Y, Getachew B, Mendieta L, Palafox-S?nchez V, Tsytsarev V, Manaye KF, Tinkov AA, da Silva VDA, Aschner M. A Narrative Review on the Role of Microbiota and Microglia in Premotor Symptoms of Parkinson's Disease. Neurotox Res. 2025 Oct 31; 43(6):45.
-
Lange LM, Fang ZH, Screven L, Tan AH, Alcalay RN, Amouri R, Bovenzi R, Fenn M, Frost JLI, Jankovic J, Jasaityte S, Jaunmuktane Z, Jeon B, Sarmiento IJK, Kr?ger R, Kuhlenb?umer G, Lin CH, Pavelka L, Peri?an MT, Sassi SB, Schirinzi T, Shin JH, Shulman JM, Tay YW, Uitti R, Warner T, Wszolek ZK, Wu L, Wu RM, Zeuner KE, Blauwendraat C, Singleton A, Mencacci NE, Morris HR, Lim SY, Lohmann K, Klein C. Rare but Relevant? Assessing Variants in Dystonia-Linked Genes in Parkinson's Disease. Mov Disord. 2026 Jan; 41(1):247-259.
-
Shaw CA, Williams CJ, Tan T, Illera D, Di N, Shulman JM, Belmont JW. The Causal Pivot: A structural approach to genetic heterogeneity and variant discovery in complex diseases. Am J Hum Genet. 2025 Sep 04; 112(9):2232-2246.
-
O'Connor JL, Fountos DM, Firouzan B, Azizi F, Ghasemi R, Kashfi K. The role of gasotransmitters in Parkinson's disease: Interplay of nitric oxide, carbon monoxide, and hydrogen sulfide. Neurotherapeutics. 2025 Oct; 22(6):e00710.
-
Firouzan B, Ghasemi R, Tetteh MT, Matson JB, Kashfi K. NOSH-aspirin (NBS-1120) attenuates motor defects and dopaminergic neuron degeneration in a rat model of Parkinson's disease. Eur J Pharmacol. 2025 Sep 05; 1002:177733.
-
Hall DA, Shulman JM, Singleton A, Bandres Ciga S, S Tosin MH, Ouyang B, Shulman L. Racial Disparities in Parkinson Disease Clinical Phenotype, Management, and Genetics: Protocol for a Prospective Observational Study. JMIR Res Protoc. 2025 Apr 07; 14:e60587.
-
Spargo TP, Sands CF, Juan IR, Mitchell J, Ravanmehr V, Butts JC, De-Paula RB, Kim Y, Hu F, Wang Q, Vitsios D, Garg M, Middleton L, Tyrlik M, Messa M, Del Angel G, Calame DG, Saade H, Robak L, Hollis B, Cuddapah VA, Zoghbi HY, Shulman JM, Petrovski S, Al-Ramahi I, Tachmazidou I, Dhindsa RS. Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson's disease. Cell Rep. 2025 Mar 25; 44(3):115355.
-
Krening E, Dy Closas AMF, Yu JRT, Seto TB, Terpak L, Bruno MK. Filipinos and Parkinson's disease: A scoping review of the literature. Parkinsonism Relat Disord. 2025 Mar; 132:107271.
-
Ma Y, Farris CM, Weber S, Schade S, Nguyen H, P?rez-Soriano A, Giraldo DM, Fern?ndez M, Soto M, C?mara A, Painous C, Mu?oz E, Valldeoriola F, Mart? MJ, Clarimon J, Kallunki P, Ma TC, Alcalay RN, Gomes BF, Blennow K, Zetterberg H, Constantinescu J, Mengel D, Kadam V, Parchi P, Brockmann K, Tropea TF, Siderowf A, Synofzik M, Kang UJ, Compta Y, Svenningsson P, Mollenhauer B, Concha-Marambio L. Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study. Lancet Neurol. 2024 12; 23(12):1225-1237.
-
Ahn JH, Kim BS, Han KD, Choi HL, Jung W, Cho JW, Youn J, Shin DW. Risk of Parkinson's disease in spinal cord injury: a nationwide cohort study in South Korea. Sci Rep. 2024 10 03; 14(1):23016.